We transduced mouse iPSDCs (miPSDCs) with the CEA gene and examined whether these genetically modified DCs could induce strong therapeutic antitumor immune responses against tumour cells expressing CEA in CEA transgenic mice. This evidence concerns the gene CEACAM5 and neoplasm.